Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R.

J Hepatol. 2006 Jul;45(1):60-71. Epub 2006 Feb 8.

PMID:
16515819
2.

Amelioration of hepatic fibrosis by NK cell activation.

Muhanna N, Abu Tair L, Doron S, Amer J, Azzeh M, Mahamid M, Friedman S, Safadi R.

Gut. 2011 Jan;60(1):90-8. doi: 10.1136/gut.2010.211136. Epub 2010 Jul 26.

PMID:
20660699
3.

Lymphocyte-hepatic stellate cell proximity suggests a direct interaction.

Muhanna N, Horani A, Doron S, Safadi R.

Clin Exp Immunol. 2007 May;148(2):338-47.

4.

Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.

Horani A, Muhanna N, Pappo O, Melhem A, Alvarez CE, Doron S, Wehbi W, Dimitrios K, Friedman SL, Safadi R.

Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G628-38. Epub 2006 Oct 12.

5.

Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice.

Ochi M, Ohdan H, Mitsuta H, Onoe T, Tokita D, Hara H, Ishiyama K, Zhou W, Tanaka Y, Asahara T.

Hepatology. 2004 May;39(5):1321-31.

PMID:
15122761
6.
7.

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.

Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL.

Gastroenterology. 2004 Sep;127(3):870-82.

PMID:
15362042
8.

Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.

Glässner A, Eisenhardt M, Kokordelis P, Krämer B, Wolter F, Nischalke HD, Boesecke C, Sauerbruch T, Rockstroh JK, Spengler U, Nattermann J.

J Hepatol. 2013 Sep;59(3):427-33. doi: 10.1016/j.jhep.2013.04.029. Epub 2013 May 9.

PMID:
23665286
9.

Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure.

Zou Y, Chen T, Han M, Wang H, Yan W, Song G, Wu Z, Wang X, Zhu C, Luo X, Ning Q.

J Immunol. 2010 Jan 1;184(1):466-75. doi: 10.4049/jimmunol.0900687. Epub 2009 Nov 30.

10.

Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.

Christianson SW, Greiner DL, Schweitzer IB, Gott B, Beamer GL, Schweitzer PA, Hesselton RM, Shultz LD.

Cell Immunol. 1996 Aug 1;171(2):186-99.

PMID:
8806787
11.

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.

Gao B, Radaeva S, Jeong WI.

Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):173-80. doi: 10.1586/17474124.1.1.173. Review.

PMID:
19072444
12.

Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.

Kawahara T, Douglas DN, Lewis J, Lund G, Addison W, Tyrrell DL, Churchill TA, Kneteman NM.

Transpl Int. 2010 Sep;23(9):934-43. doi: 10.1111/j.1432-2277.2010.01063.x. Epub 2010 Feb 17.

13.

The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.

Elsner L, Muppala V, Gehrmann M, Lozano J, Malzahn D, Bickeböller H, Brunner E, Zientkowska M, Herrmann T, Walter L, Alves F, Multhoff G, Dressel R.

J Immunol. 2007 Oct 15;179(8):5523-33.

14.

CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.

Hintermann E, Bayer M, Pfeilschifter JM, Luster AD, Christen U.

J Autoimmun. 2010 Dec;35(4):424-35. doi: 10.1016/j.jaut.2010.09.003. Epub 2010 Oct 6.

15.

Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.

Gäbele E, Mühlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B, Wiest R, Schölmerich J, Obermeier F, Hellerbrand C.

Biochem Biophys Res Commun. 2008 Nov 14;376(2):271-6. doi: 10.1016/j.bbrc.2008.08.096. Epub 2008 Aug 28.

PMID:
18760996
16.
17.

Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes.

Ginsburg I, Koren E, Horani A, Mahamid M, Doron S, Muhanna N, Amer J, Safadi R.

Clin Exp Immunol. 2009 Jul;157(1):155-64. doi: 10.1111/j.1365-2249.2009.03936.x.

18.

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.

Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, Breitkopf K, Weng H, Mertens PR.

Gastroenterology. 2008 Aug;135(2):642-59. doi: 10.1053/j.gastro.2008.04.038. Epub 2008 May 15.

19.

The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.

Eisenhardt M, Glässner A, Krämer B, Körner C, Sibbing B, Kokordelis P, Nischalke HD, Sauerbruch T, Spengler U, Nattermann J.

PLoS One. 2012;7(7):e38846. doi: 10.1371/journal.pone.0038846. Epub 2012 Jul 5.

20.

NK cells play a critical role in the regulation of class I-deficient hemopoietic stem cell engraftment: evidence for NK tolerance correlates with receptor editing.

Huang Y, Rezzoug F, Xu H, Chilton PM, Schanie CL, Fugier-Vivier I, Ildstad ST.

J Immunol. 2005 Sep 15;175(6):3753-61.

Supplemental Content

Support Center